Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction

By sjmartinez • November 22, 2023

Lau ES, Roshandelpoor A, Zarbafian S, Wang D, Guseh JS, Allen N, Varadarajan V, Nayor M, Shah RV, Lima JAC, Shah SJ, Yu B, Alotaibi M, Cheng S, Jain M, Lewis GD, Ho JE. Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction. Nat Commun. 2023 Nov 20;14(1):7557. doi: 10.1038/s41467-023-43363-3. PMID: 37985769; PMCID: PMC10662264.

Tags: Cardiology/Epi, Cedars Sinai DoM, Publications

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]

Authors’ Perspective-Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update

Kobashigawa J, Zuckermann A, Potena L, Ardehali A, Berman M, Chang PP, Esmailian F, Farr M, Hall S, Hsich E, Khush K, Kittleson M, Leprince[...]

Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow

Ali FZ, Packard RRS. Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow. J Nucl Cardiol. 2026 Apr;58:102674. doi: 10.1016/j.nuclcard.2026.102674. PMID:[...]